Results 51 to 60 of about 197,157 (312)

chroGPS, a global chromatin positioning system for the functional analysis and visualization of the epigenome [PDF]

open access: yes, 2013
Development of tools to jointly visualize the genome and the epigenome remains a challenge. chroGPS is a computational approach that addresses this question.
Font-Burgada, Joan   +3 more
core   +1 more source

JMJD family proteins in cancer and inflammation

open access: yesSignal Transduction and Targeted Therapy, 2022
The occurrence of cancer entails a series of genetic mutations that favor uncontrollable tumor growth. It is believed that various factors collectively contribute to cancer, and there is no one single explanation for tumorigenesis.
Wang Manni   +4 more
doaj   +1 more source

Hitting histone demethylases [PDF]

open access: yesScience-Business eXchange, 2012
A GSK–Structural Genomics Consortium team has identified the first potent and selective histone demethylase inhibitor and shown that the molecule dampens the macrophage inflammatory response. The pharma now is focusing on internal efforts and external approaches to exploring potential therapeutic applications of the inhibitor.
openaire   +1 more source

Lung Cancer Therapy Targeting Histone Methylation: Opportunities and Challenges

open access: yesComputational and Structural Biotechnology Journal, 2018
Lung cancer is one of the most common malignancies. In spite of the progress made in past decades, further studies to improve current therapy for lung cancer are required.
Yuchen Chen   +5 more
doaj   +1 more source

Targeting epigenetic regulators to overcome drug resistance in cancers

open access: yesSignal Transduction and Targeted Therapy, 2023
Drug resistance is mainly responsible for cancer recurrence and poor prognosis. Epigenetic regulation is a heritable change in gene expressions independent of nucleotide sequence changes.
Nan Wang, Ting Ma, Bin Yu
doaj   +1 more source

Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription [PDF]

open access: yes, 2014
TET enzymes are the epigenetic factors involved in the formation of the Sixth DNA base 5-hydroxymethylcytosine, whose deregulation has been associated with tumorigenesis.
Bacalini, MARIA GIULIA   +9 more
core   +6 more sources

Genome-wide gene expression profiling to investigate molecular phenotypes of Arabidopsis mutants deprived in distinct histone methyltransferases and demethylases

open access: yesGenomics Data, 2015
Histone lysine (K) methylation is a type of epigenetic modification involved in regulation of DNA-based processes, including transcription, replication and repair.
Wei Zhao   +3 more
doaj   +1 more source

The emerging roles for histone demethylases in the modulation of signaling pathways

open access: yesBiomolecular Concepts, 2013
Since their discovery in 2004, histone demethylases have emerged as key regulators of chromatin. Recent studies have started to reveal the interconnections between histone demethylases and signaling pathways, suggesting that this interplay drives ...
Di Stefano Luisa, Dyson Nicholas J.
doaj   +1 more source

Highly selective inhibition of histone demethylases by de novo macrocyclic peptides

open access: yesNature Communications, 2017
The JmjC histone demethylases (KDMs) are linked to tumour cell proliferation and are current cancer targets; however, very few highly selective inhibitors for these are available.
A. Kawamura   +18 more
semanticscholar   +1 more source

Histone lysine demethylases in breast cancer [PDF]

open access: yesCritical Reviews in Oncology/Hematology, 2013
Histone lysine demethylases (KDMs) have been recently discovered in mammals and have been nicknamed "erasers" for their ability to remove methyl groups from histone substrates. In cancer cells, KDMs can activate or repress gene transcription, behaving as oncogenes or tumor suppressors depending upon the cellular context.
PAOLICCHI, ELISA   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy